isomethyleugenol has been researched along with Atypical Endometrial Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, M; Inoue, M; Kanaya, T; Kyo, S; Maida, Y; Mizumoto, Y; Nakamura, M; Sakaguchi, J; Takakura, M | 1 |
| del Senno, L; Hanau, S; Mollica, G; Pansini, FS; Piva, R; Rimondi, AP | 1 |
2 other study(ies) available for isomethyleugenol and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Base Pair Mismatch; Base Sequence; Carrier Proteins; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Frameshift Mutation; Humans; Immunohistochemistry; Japan; Methylation; Microsatellite Repeats; Middle Aged; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; Phosphoric Monoester Hydrolases; Polymerase Chain Reaction; Precancerous Conditions; Promoter Regions, Genetic; PTEN Phosphohydrolase; Tumor Suppressor Proteins | 2005 |
Hypomethylated state of estrogen receptor gene in endometrial carcinomas.
Topics: Adenocarcinoma; Cell Transformation, Neoplastic; DNA, Neoplasm; Endometrial Hyperplasia; Female; Humans; Methylation; Receptors, Estrogen; Uterine Neoplasms | 1988 |